TrialOncotarget2016

Safety and efficacy of sorafenib therapy in patients with hepatocellular carcinoma: final outcome from the Chinese patient subset of the GIDEON study.

Sheng-Long Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.